Trial intelligence / Profile preview

Raloxifene as Adjuvant Treatment for Negative Symptoms of Schizophrenia in Postmenopausal Women

NCT01041092Phase 4Completed

Sponsor
Fundació Sant Joan de Déu
Start
Jun 2004
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raloxifene in schizophrenia, sponsored by Fundació Sant Joan de Déu. Started Jun 2004; status: completed.

02

Drugs

raloxifene
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01041092.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01041092.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call